Bone and Cancer
Bone and Cancer
Bone and CancerBone and Cancer Foundation, PO Box 287452 Bone and Cancer New York, NY 10128-0025  
Toll Free: 888 862-0999 Bone and Cancer Email: bcfdn@aol.com  
Bone and Cancer

Clinical Trials

FDA Approved Drugs by Name
Company: Eli Lilly

Search by brand name for drugs approved by the Food and Drug Administration (FDA) for sale in the United States. Each listing contains a brief description of the indication for use. Click on the drug name for a complete product profile, including general information, clinical trial results, side effects and manufacture information.

Adcirca (tadalafil)

For the treatment of pulmonary arterial hypertension

Alimta (pemetrexed for injection)

For the treatment of non-small cell lung cancer

Alimta (pemetrexed for injection)

For the treatment of malignant pleural mesothelioma

Cialis (tadalafil)

Oral agent for the treatment for erectile dysfunction

Cymbalta (duloxetine)

For the treatment of major depressive disorder

Cyramza (ramucirumab)

For the treatment of gastric cancer

Cyramza (ramucirumab)

For the treatment of hepatocellular carcinoma with elevated alpha-fetoprotein (AFP)

Efient (prasugrel)

for the prevention of thrombotic cardiovascular complications in acute coronary syndromes

Emgality (galcanezumab-gnlm)

For the preventive treatment of migraine and episodic cluster headache in adults

Evista (raloxifene hydrochloride)

For the treatment/prevention of osteoporosis and reduction of breast cancer risk in postmenopausal women

Evista (raloxifene hydrochloride)

Osteoporosis treatment

Evista (raloxifene hydrochloride)

Treatment for the prevention of osteoporosis

Forteo (teriparatide)

For the treatment of Osteoporosis in postmenopausal women and men who are at high risk for a fracture.

Gemzar (gemcitabine HCL)

Treatment for Lung Cancer

Gemzar (gemcitabine HCL)

Treatment for pancreatic cancer

Glucagon

Treatment for severe Hypoglycemia

Glucagon

Treatment for severe hypoglycemia associated with diabetes.

Humalog (insulin lispro)

Treatment for type I and type II diabetes

Humatrope (somatropin [rDNA origin] for injection)

Treatment for Somatropin Deficiency Syndrome

Jentadueto (linagliptin plus metformin hydrochloride)

For the treatment of type II diabetes

Lartruvo (olaratumab)

For the treatment of soft tissue sarcoma

Olumiant (baricitinib)

For the treatment of moderate to severe rheumatoid arthritis with inadequete response to TNF antagonist therapies

Portrazza (necitumumab)

For the treatment of metastatic squamous non-small cell lung cancer

Prozac Weekly (fluoxetine HCl)

For the treatment of depression

Strattera (atomoxetine HCl)

For the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children, adolescents and adults.

Taltz (ixekizumab)

For the treatment of plaque psoriasis and active psoriatic arthritis

Trulicity (dulaglutide)

To improve glycemic control in type II diabetics

Verzenio (abemaciclib)

For the treatment of HR+, HER2- breast cancer

Xigris (drotrecogin alfa [activated])

For the treatment of severe sepsis

Zyprexa

Treatment of the symptoms of psychotic disorders

 How To Order Publications:
  Glossary
  FAQ

Information About

Clinical Trials



 

 

 

 

 

 

 

 

 

 

 


 

 

 

 

 

 

 


  Copyright 2011 - The Bone and Cancer Foundation